FR2269346B1 - - Google Patents

Info

Publication number
FR2269346B1
FR2269346B1 FR7513671A FR7513671A FR2269346B1 FR 2269346 B1 FR2269346 B1 FR 2269346B1 FR 7513671 A FR7513671 A FR 7513671A FR 7513671 A FR7513671 A FR 7513671A FR 2269346 B1 FR2269346 B1 FR 2269346B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7513671A
Other versions
FR2269346A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Archimica SpA
Original Assignee
Istituto Chemioterapico Italiano SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Chemioterapico Italiano SpA filed Critical Istituto Chemioterapico Italiano SpA
Publication of FR2269346A1 publication Critical patent/FR2269346A1/fr
Application granted granted Critical
Publication of FR2269346B1 publication Critical patent/FR2269346B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR7513671A 1974-05-02 1975-04-30 Expired FR2269346B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68367/74A IT1055560B (it) 1974-05-02 1974-05-02 Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali

Publications (2)

Publication Number Publication Date
FR2269346A1 FR2269346A1 (fr) 1975-11-28
FR2269346B1 true FR2269346B1 (fr) 1980-02-29

Family

ID=11309152

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7513671A Expired FR2269346B1 (fr) 1974-05-02 1975-04-30

Country Status (8)

Country Link
US (1) US3991190A (fr)
AU (1) AU8070675A (fr)
BE (1) BE828555A (fr)
CA (1) CA1041427A (fr)
DE (1) DE2519394C3 (fr)
FR (1) FR2269346B1 (fr)
GB (1) GB1503675A (fr)
IT (1) IT1055560B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1193590B (it) * 1983-01-07 1988-07-08 Loris Jacopo Bononi Derivati amino-alchil-solfonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1212737B (it) * 1983-05-06 1989-11-30 Daniele Gatti Derivati pirimidinici ad azione antivirale.
CN1019575B (zh) * 1988-02-19 1992-12-23 石原产业株式会社 2-氨基-4，6-二氯嘧啶的生产方法
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
WO1995007265A1 (fr) * 1993-09-10 1995-03-16 E.I. Du Pont De Nemours And Company Procede ameliore permettant de preparer la 2-amino-4,6-dichloropyrimidine
CA2173964A1 (fr) * 1993-10-15 1995-04-20 Jess G. Thoene Prevention de l'infection par le vih
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
AT402924B (de) * 1994-05-13 1997-09-25 Chemie Linz Gmbh Verfahren zur herstellung von 2-amino-4,6-dichloro-pyrimidin
DE4419118A1 (de) * 1994-06-01 1995-12-07 Chemie Linz Deutschland Verfahren zur Herstellung von 2-Amino-4,6-dichloro-pyrimidin
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
FR2890561B1 (fr) * 2005-09-09 2012-03-09 Pharma Pass France S A S Composition ophtalmique contenant un sel de cysteamine
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
WO2010138419A2 (fr) * 2009-05-23 2010-12-02 Obio Pharmaceutical (H.K.) Ltd. Matières et procédés de traitement d'infections virales
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition

Also Published As

Publication number Publication date
DE2519394A1 (de) 1976-01-29
GB1503675A (en) 1978-03-15
FR2269346A1 (fr) 1975-11-28
BE828555A (fr) 1975-08-18
AU8070675A (en) 1976-11-04
US3991190A (en) 1976-11-09
IT1055560B (it) 1982-01-11
DE2519394C3 (de) 1980-12-11
DE2519394B2 (de) 1980-04-17
CA1041427A (fr) 1978-10-31

Similar Documents

Publication Publication Date Title
BR7501663A (fr)
AU7459374A (fr)
AU495028B2 (fr)
JPS50127517A (fr)
JPS50129925U (fr)
BG23065A1 (fr)
CH573827A5 (fr)
BG19629A1 (fr)
BG27063A3 (fr)
BG19667A1 (fr)
BG19896A1 (fr)
BG19982A1 (fr)
BG20022A1 (fr)
BG20237A1 (fr)
BG20425A1 (fr)
BG20446A1 (fr)
BG20857A1 (fr)
BG21135A1 (fr)
BG21493A1 (fr)
BG21814A1 (fr)
BG22015A1 (fr)
BG22275A1 (fr)
BG26511A3 (fr)
BE829576A (fr)
BG26507A3 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
ST Notification of lapse